The University of Melbourne’s Departments of Biochemistry and Molecular Biology, and Pharmacology have over recent years identified cone shell venom as a potential treatment for chronic pain in humans.
Researchers continue to develop the research into a commercialised product. One of the venom peptides identified is currently in phase two of clinical trials.